These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 30343982)
21. White Matter Lesion Progression and Cognitive Function Over 5 Years in a Young Susceptible Population. Nyquist PA; Yanek LR; Kral BG; Becker LC; Vaidya D; Becker DM Neuroepidemiology; 2017; 49(1-2):62-63. PubMed ID: 28850949 [No Abstract] [Full Text] [Related]
22. Contribution of language studies to the understanding of cognitive impairment and its progression over time in Parkinson's disease. Auclair-Ouellet N; Lieberman P; Monchi O Neurosci Biobehav Rev; 2017 Sep; 80():657-672. PubMed ID: 28782623 [TBL] [Abstract][Full Text] [Related]
23. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology. Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894 [TBL] [Abstract][Full Text] [Related]
25. Association of homocysteine, folate, and white matter hyperintensities in Parkinson's patients with different motor phenotypes. Shen Y; Dong ZF; Pan PL; Xu G; Huang JY; Liu CF Neurol Sci; 2019 Sep; 40(9):1855-1863. PubMed ID: 31055730 [TBL] [Abstract][Full Text] [Related]
26. Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease. Ong M; Foo H; Chander RJ; Wen MC; Au WL; Sitoh YY; Tan L; Kandiah N J Neurol Sci; 2017 Jun; 377():122-126. PubMed ID: 28477681 [TBL] [Abstract][Full Text] [Related]
27. Exploring the relationship between motor impairment, vascular burden and cognition in Parkinson's disease. Stojkovic T; Stefanova E; Soldatovic I; Markovic V; Stankovic I; Petrovic I; Agosta F; Galantucci S; Filippi M; Kostic V J Neurol; 2018 Jun; 265(6):1320-1327. PubMed ID: 29572571 [TBL] [Abstract][Full Text] [Related]
28. The impact of white matter lesions on the cognitive outcome of subthalamic nucleus deep brain stimulation in Parkinson's disease. Blume J; Lange M; Rothenfusser E; Doenitz C; Bogdahn U; Brawanski A; Schlaier J Clin Neurol Neurosurg; 2017 Aug; 159():87-92. PubMed ID: 28582689 [TBL] [Abstract][Full Text] [Related]
29. Effect of olfactory impairment and white matter hyperintensities on cognition in Parkinson's disease. Ham JH; Lee JJ; Sunwoo MK; Hong JY; Sohn YH; Lee PH Parkinsonism Relat Disord; 2016 Mar; 24():95-9. PubMed ID: 26776568 [TBL] [Abstract][Full Text] [Related]
31. Regional volumetric change in Parkinson's disease with cognitive decline. Gee M; Dukart J; Draganski B; Wayne Martin WR; Emery D; Camicioli R J Neurol Sci; 2017 Feb; 373():88-94. PubMed ID: 28131236 [TBL] [Abstract][Full Text] [Related]
32. Progression of subcortical atrophy in mild Parkinson's disease and its impact on cognition. Foo H; Mak E; Yong TT; Wen MC; Chander RJ; Au WL; Sitoh YY; Tan LC; Kandiah N Eur J Neurol; 2017 Feb; 24(2):341-348. PubMed ID: 27943468 [TBL] [Abstract][Full Text] [Related]
33. Cerebral autoregulation and white matter lesions in Parkinson's disease and multiple system atrophy. Indelicato E; Fanciulli A; Poewe W; Antonini A; Pontieri FE; Wenning GK Parkinsonism Relat Disord; 2015 Dec; 21(12):1393-7. PubMed ID: 26578037 [TBL] [Abstract][Full Text] [Related]
34. Changes in anatomical and functional connectivity of Parkinson's disease patients according to cognitive status. Chen B; Fan GG; Liu H; Wang S Eur J Radiol; 2015 Jul; 84(7):1318-24. PubMed ID: 25963506 [TBL] [Abstract][Full Text] [Related]
35. Cognition in Parkinson's Disease. O'Callaghan C; Lewis SJG Int Rev Neurobiol; 2017; 133():557-583. PubMed ID: 28802933 [TBL] [Abstract][Full Text] [Related]
36. Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease. Weintraub D; Caspell-Garcia C; Simuni T; Cho HR; Coffey CS; Aarsland D; Alcalay RN; Barrett MJ; Chahine LM; Eberling J; Espay AJ; Hamilton J; Hawkins KA; Leverenz J; Litvan I; Richard I; Rosenthal LS; Siderowf A; York M; Ann Clin Transl Neurol; 2020 Apr; 7(4):449-461. PubMed ID: 32285645 [TBL] [Abstract][Full Text] [Related]
37. The contribution of white matter lesions (WML) to Parkinson's disease cognitive impairment symptoms: A critical review of the literature. VeselĂ˝ B; Rektor I Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S166-70. PubMed ID: 26391185 [TBL] [Abstract][Full Text] [Related]
38. Temporal Lobe and Frontal-Subcortical Dissociations in Non-Demented Parkinson's Disease with Verbal Memory Impairment. Tanner JJ; Mareci TH; Okun MS; Bowers D; Libon DJ; Price CC PLoS One; 2015; 10(7):e0133792. PubMed ID: 26208170 [TBL] [Abstract][Full Text] [Related]
39. Neural Correlates of Cognitive Impairment in Parkinson's Disease: A Review of Structural MRI Findings. Hall JM; Lewis SJG Int Rev Neurobiol; 2019; 144():1-28. PubMed ID: 30638452 [TBL] [Abstract][Full Text] [Related]
40. Cortical thinning correlates of changes in visuospatial and visuoperceptual performance in Parkinson's disease: A 4-year follow-up. Garcia-Diaz AI; Segura B; Baggio HC; Uribe C; Campabadal A; Abos A; Marti MJ; Valldeoriola F; Compta Y; Bargallo N; Junque C Parkinsonism Relat Disord; 2018 Jan; 46():62-68. PubMed ID: 29132765 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]